Health ❯ Healthcare ❯ Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease Symptoms and Diagnosis Disease Progression Biomarkers Aging-related Treatments Cognitive Decline Amyloid-beta Proteins Research Innovations Diagnosis Plasmaféresis Patient Support Programs Diagnosis and Treatment Risk Assessment Clinical Trials Treatment Strategies Amyloid Beta Targeting Mild Cognitive Impairment Research Studies Diagnosis Methods Cognitive Function FTLD-TDP Clinical Studies Molecular Biology Drug Testing Cognitive Assessment Amyloid-beta Oligomers Neuroinflammation Hormone Therapy Treatment Methods Patient Care Treatment Innovations

Estrogen-Only Menopausal Therapy Linked to Fewer Alzheimer’s Markers on Autopsy

Experts call the result associative not causal; they say randomized trials must test timing, formulation and subgroup effects

ProMIS Reports Blinded Six‑Month Interim Data Showing No ARIA‑E in PMN310 Phase 1b Trial

Blood Tests Map Decades-Long Alzheimer’s Changes and Point to Earlier Screening

Handwriting on Tablets Signals Cognitive Impairment in Care-Home Study

MIT Team Coaxes Chaotic Fiber Laser Into ‘Pencil Beam’ for Fast 3D Brain-Barrier Imaging

UK Approves Once-Every-Four-Weeks IV Maintenance Dosing for Leqembi in Early Alzheimer’s

First Noninvasive MRI Maps Brain’s Tiniest Vessel Pulses, Tying Aging and Hypertension to Deep White Matter

Harvard Team Releases PDGrapher, an AI to Predict Gene and Drug Combos That Reverse Diseased Cell States

Alzheimer’s Biomarkers Emerge in Middle Age With Maternal and Kidney Associations